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Decrease in color of human hair in the course
of drug therapy is an unusual and arresting phe-
nomenon. In our experience, it was limited to
blonde subjects following administration of
chioroquine diphosphate.t This unique restric-
tion prompted the present investigation.
Loss of hair color following the administration
of chloroquine was reported by Alving (1) in
1950 when the drug was studied for chronic
toxicity. All blonde subjects developed the
changes on a daily dose of 0.3 Gm. (expressed
as the base) and one of two persons developed
depigmentation of hair on a weekly dose of
0.5 Gm. The effect disappeared when the dosage
was reduced. Tye (2) mentioned slight loss of hair
color in one blonde and one red-haired individual.
Depigmentation of the hair in three cases out of
eighty treated for lupus erythematosus was
noted by Lowenthal (3). The effect occurred in
from three to seven weeks after beginning treat-
ment with 0.5 to 0.75 Gm. daily. The hair re-
turned to its natural color about three weeks
after treatment was stopped, leaving a band of
depigmented hair in an apparently normal head
of hair. The depigmentation occurred on the
scalp in all patients, on the eyebrows in two, and
there was no effect on the lanugo hair. Fluores-
cence related to the presence of chloroquine was
absent. All three cases were natural blondes.
Lowenthal had given similar doses to brunettes
but did not observe loss of hair color. Schoch (3)
observed the depigmentation in one brown-haired
woman. Payne (4) noted decrease in hair color
in two patients with rheumatoid arthritis on 500
mgms. chloroquine daily. Reversal in the hair
pigmentation occurred in a young white woman.
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t Also known as Aralen Dephosphate, Nivaquine
B, Sanoquin, Tanakan and Resochin.
(Schoch (5)) She had been blonde until age
twenty, at which time her hair had spontane-
ously darkened sufficiently to be regarded as
brunette. Under heavy antimalarial therapy
(primarily chloroquine) her hair lightened in
color to the point of being definitely blonde.
Fuld (6) reported two cases of depigmentation of
hair, and Sharvill (7) reported one in which the
eyebrows as well as the scalp hair became white
(in a brown-haired subject).
Loss of -hair color has also been reported (5)
following prolonged administration of hydroxy-




Case No. 1. E. D., a ten-year-old female child
was treated for subacute lupus erythematosus
with chloroquine, 250 mgms. daily. Her hair was
light reddish-blonde in color. There was no change
in hair color on this dosage. When the dosage of
chloroquinc was increased to 750 mgms. daily,
some of her hair became depigmentcd. This change
in color was also demonstrable by filtered ultra-
violet light. When the dosage was maintained at
250 mgms. daily, there was no depigmentation.
Case No. 2. D. M., an eighteen-year-old female,
was treated for systemic lupus erythematosus with
750 mgms. of chloroquine daily. Her hair color was
reddish-blonde. It became depigmented after
taking chloroquine for four months. The hair of
the eyelashes and eyebrows showed a similar
effect.
Case No. 3. M. H., a ten-year-old boy, was
treated for rheumatic fever with chloroquine,
250-500 mgms. for three months. His hair, which
was reddish in color, became very light in color.
Case No. 4. P. M., a sixteen-year-old man, with
light brown hair, was treated for atopic derma-
titis with chloroquinc, 750 mgms. daily. His hair
became depigmented.
Case No. 5. H. H., a twenty-eight-year-old
woman, with red-brown hair, was given
1,000 mgms. of chloroquine daily for treatment of
systemic lupus crythematosus. Her hair became
depigmented.
Case No. 6. M. T., an eleven-year-old girl, with
light brown hair, developed depigmentation of
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Case No. 1. L. L., a twenty-eight-year-old man,
with dark brown hair was treated for atopic derma-
titis with chioroquine. No change in hair color
was noted after three months of chioroquine,
750 mgms. daily.
Case No. 2. A. C., a thirty-seven-year-old man,
was given chloroquine, 250 to 500 mgms. daily
and there was no depigmentation of his dark
brown hair.
Case No. 3. F. McC., a fifty-five-year-old Negro
woman, with sarcoidosis, received 750 mgms.
daily for 36 months with no change in hair color.
EXPERIMENTAL STUDIES AND RESULTS
FIG. 1. (M. T.) Localized depigmentation of
hair following the administration of chloroquine,
dose 500 milligrams a day. This patient had light
red-brown hair.
the hair following the use of chloroquine, 500
mgms. daily, for the treatment of Still's disease.
The patient showed the banding effect of starting
and stopping the drug.
Case No. 7. I. M., a thirty-two-year-old, red
haired woman took chloroquine, 750 mgms. a day
for the treatment of light sensitivity. In two
months time her hair became lighter in color. She
described it as being "seven shades lighter than
previously". It became repigmented when the
drug was discontinued but her hair became brown
rather than red.
Case No. 8. Mrs. T., a fifty-year-old woman,
with light brown hair, developed depigmentation
of the scalp hair, eyebrows and eyelashes, after
taking the drug in 250 mgms. daily doses for two
months. When Plaquenil (hydroxychloroquine)
was substituted there was no depigmentation.
Case No. 9. I. S., a thirty-nine-year-old, red-
haired woman was treated with chloroquine,
250 mgms. daily. Her scalp hair became lighter in
color but the normal pigmentation retnrned with
discontinuation of the drug.
Case No. .10. E. S., a seventeen-year-old
woman, with blonde hair, was treated with chloro-
quine, 250 mgms. daily. Her hair became depig-
mented in localized areas.
The following case reports illustrate the ab-
sence of change in hair color in dark-haired sub-
jects.
An attempt was made to inhibit pigment for-
mation in three different classes, insects, birds
and mammals. The yellow pigment of certain
insect eyes is known to be derived from trypto-
phane - formylkynurenin - kynurenin - hydroxy-
kynurenin, being a phenoxazone (Sa). The nature
of the yellow-red pigment of Rhode Island Red
fowl and yellow, red and rust-colored guinea pigs
is not known.
A. Experiments with the Dipteran Fly
(Phormia Regina)
The eggs were sterilized and larvae fed on a
sterilized medium made up of casein, yeast pow-
der, cholesterol, inorganic salts and water.
Chloroquine phosphate in percentages from 0.2
to 0.000002 was added to the food. Both con-
trols and flies that survived the chioroquine
treatment, when their heads were digested with
methanol-llCl yielded a yellow pigment, which
on reduction turned pink. This would suggest
that the phenoxazone pigment is formed in the
presence of chloroquine and that the tryptophane-
formylkynurenin -kynurenin-hydroxykynurenin
pathway is not interfered with by chloroquine.
B. Experiments with Fowl
Because of its close resemblance (tinctorially)
to human reddish or blonde hair, the Rhode
Island Red chick was utilized. Chloroquine in a
3 x 10 i molar concentration (0.1 ml.) was in-
jected into the yolk sac on the sixth day, the bird
being hatched on the twenty-first day. The
feathers of the experimental chick were much
lighter in color than those of the control. (See
Fig. 2)
In a similar experiment, using the Black
Minorea chick, no change in pigmentation was
observed.
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FIG. 2. (The chickens). Depigmentation of
Rhode Island Red chicken, following the inocula-
tion of 0.1 ml. chioroquine in a 3 X 10 molar
concentration. Control animal on right side of
picture.
C. Experiments with Variously Colored
Guinea Pigs
In vivo studied were done, using black agouti,
red and yellow guinea pigs, chioroquine being
given orally (10 mgms. per kg. body weight) for
periods up to 50 days. No change in hair color
was noted in any of the animals.
DISCUSSION
Most of the clinical reports on the inhibition
of hair pigmentation by chloroquine have de-
scribed the phenomenon in blonde, yellow or
red-haired individuals; however, there are some
reports of this change occurring in dark brown
hair. A color change has not yet been observed
in the black-haired Japanese or Negro patients
receiving prolonged and large doses of chloro-
quine.
It has been possible to demonstrate an inhibi-
tion of yellow-red pigment formation in the
Rhode Island Red fowl but not the Black
Minorca. This suggests that the inhibitory effect
of chloroquine in fowl is not on the tyrosine-
melanin pathway but the metabolic pathway
leading to yellow-red pigment formation in this
species. In addition, ehloroquine was found in
some preliminary studies to have little or no in
vitro effect on the tyrosine-mammalian tyrosinase
reaction. In these experiments there was a sig-
nificant lengthening of the induction period in
the oxidation of tyrosine but this could not ac-
count for the observed clinical inhibitory effects.
In the past few years there has been specula-
tion on the possibility that yellow-red pigment
in the feather and hair may be derived from
tryptophane. The problem of the nature of hair
pigment has been recently summarized (9), and
although the mechanism of brown-black pigment
formation from tyrosine is reasonably well-
established, the precise pathway leading to
yellow-red pigment is not yet clear. Various tryp-
tophane metabolites have been implicated, mostly
by analogy with yellow-red pigment formation
in lower forms; and a scheme originally proposed
by Butenandt (8a) for the inter-relationship of
the tyrosine-melanin pathway and tryptophane-
ommochrome pathway has been suggested as a
mode of yellow-red pigment formation in human
hair. Three facts support but do not prove this
hypothesis: (1) Yellow-red pigment of mammals
(mice, rats, guinea pigs) and red human hair
emit a bright yellow or orange fluorescence when
viewed with ultraviolet light of 3600 A. (2)
There is an abundance of tyrosinase in red
human hair bulbs. (3) Certain tryptophane inter-
mediates have been isolated from mammalian
hair including kynurenin (Rebell et at. (10)) and
3-hydroxykynurenin (11). The latter compound
inhibits the formation of melanin from tyrosine,
by melanocytes in the hair bulb (9).
Our studies did not clarify the nature of the
metabolic block produced by chloroquine, and
until more is learned about the metabolic path-
way leading to yellow-red pigment formation,
the mechanism of the inhibition of yellow-red
pigment by chloroquine will not be known. In-
deed, ehloroquine may prove to be a valuable
chemical in the unraveling of the complex path-
way leading to yellow-red pigment formation.
SUMMARY
Ten cases of decrease in reddish or blonde hair
color following chloroquine diphosphate are re-
ported. Its absence in black-haired individuals
was noted. The decrease was reversible in every
ease following withdrawal of the drug. Chloro-
quine, when fed to flies and guinea pigs failed to
produce any color change. However, feathers of
the Rhode Island Red chick were depigmented
by instillation of chloroquine into the yolk sac.
Tinder the same conditions, there was no change
in pigmentation in the Black Minorea chick.
Our observations and experiments indicate
that chloroquine interferes with the pigment for-
mation in blonde-red haired humans and in chicks
of comparable coloring. The nature of the meta
bolic block awaits further investigation.
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DISCUSSION
DR. HARVEY BLANK (Miami, Florida): A few
years ago there were a number of reports of this
phenomenon occurring in patients receiving
mephenesin carbamatc. A reduction in urinary
MSH output was noted in some of these patients.
Does chloroquine have any effect on urinary
MSH? Do the presentors think that the chloro-
quin effect on hair color is mediated by MSH?
DR. PETER FLESCH (Philadelphia, Penna.):
The finding that chioroquine depigments red
chick feathers as well as human hair is of interest
in view of the fact that trichosiderin, the iron-
containing red pigment, described by Dr.
Rothman and myself, occurs in chick feathers as
well as in human hair, but has not been found
in hair from other species. It would be interesting
to isolate trichosidcrin from hair or feathers
before and after treatment with chloroquine to see
whether or not the drug has brought about any
quantitiative or qualitative changes in this pig-
ment.
DR. EUGENE J. VAN ScOTT (Bethesda, Md.):
Does the color of hair change if the hair is soaked
in solutions of chloroquine? Has any change been
noted in the skin pigment of patients taking
chloroquine?
DE. STEPHEN ROTHMAN (Chicago, Ill.): The
quoted authors, Alving and Eichelberger, are
working at the University of Chicago. Alving
initiated the large project testing modern anti-
malarial drugs in Stateville prison.
The authors' observations are most remarka-
ble. I just wonder, like Dr. Flesch, what role the
iron pigment ("trichosiderin") of red hair may
play in this phenomenon. Although we did not
get far with the chemical identification of this
substance we had a strong suspicion that it is a
tryptophane derivative.
DR. ALLAN L. LoRINcz (Chicago, Ill.): I
would like to ask if anything happens to freckles
in persons showing loss of hair pigment during
chloroquine therapy?
DR. THOMAS B. FITZPATRICK (in closing):
Dr. Blank, we do not have any knowledge of the
effect of chloroquine on the levels of the melano-
cyte -stimulating-hormone (MSH). Nor do we
know the effect of chloroquine on skin pigmenta-
tion when applied externally or given per os.
Dn. THOMAS S. SAUNDERS (in closing): Dr.
Fitzpatrick has answered all the questions.
Many thanks to Dr. Rothman for the correc-
tion in geography.
